Glaukos Corp. (GKOS)
122.64
-3.70
(-2.93%)
USD |
NYSE |
Jun 10, 16:00
122.64
0.00 (0.00%)
After-Hours: 19:13
Glaukos EPS Diluted (Quarterly) : -0.341 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.341 |
| December 31, 2025 | -2.324 |
| September 30, 2025 | -0.2828 |
| June 30, 2025 | -0.3436 |
| March 31, 2025 | -0.3204 |
| December 31, 2024 | -0.6041 |
| September 30, 2024 | -0.389 |
| June 30, 2024 | -0.9966 |
| March 31, 2024 | -0.8237 |
| December 31, 2023 | -0.7525 |
| September 30, 2023 | -0.6254 |
| June 30, 2023 | -0.6796 |
| March 31, 2023 | -0.7232 |
| December 31, 2022 | -0.659 |
| September 30, 2022 | -0.5792 |
| June 30, 2022 | -0.9616 |
| March 31, 2022 | 0.1086 |
| December 31, 2021 | -0.4661 |
| September 30, 2021 | 0.1263 |
| June 30, 2021 | -0.3775 |
| March 31, 2021 | -0.3603 |
| December 31, 2020 | -0.2363 |
| September 30, 2020 | -0.3523 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.8998 |
| March 31, 2020 | -1.235 |
| December 31, 2019 | 0.8436 |
| September 30, 2019 | -0.3667 |
| June 30, 2019 | -0.173 |
| March 31, 2019 | -0.0371 |
| December 31, 2018 | 0.045 |
| September 30, 2018 | -0.1863 |
| June 30, 2018 | -0.15 |
| March 31, 2018 | -0.08 |
| December 31, 2017 | 0.03 |
| September 30, 2017 | 0.04 |
| June 30, 2017 | -0.10 |
| March 31, 2017 | 0.02 |
| December 31, 2016 | 0.0036 |
| September 30, 2016 | 0.03 |
| June 30, 2016 | 0.06 |
| March 31, 2016 | 0.03 |
| December 31, 2015 | -0.07 |
| September 30, 2015 | -0.07 |
| June 30, 2015 | -10.96 |
| March 31, 2015 | -0.0309 |
| March 31, 2014 | -0.1266 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Globus Medical, Inc. | 0.8995 |
| Insulet Corp. | 1.298 |
| Abbott Laboratories | 0.6165 |
| AngioDynamics, Inc. | -0.1944 |
| Alphatec Holdings, Inc. | -0.2201 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.78M |
| Revenue (Quarterly) | 150.57M |
| Total Expenses (Quarterly) | 170.35M |
| Enterprise Value | 7.199B |
| Gross Profit Margin (Quarterly) | 77.86% |
| Profit Margin (Quarterly) | -13.14% |
| Earnings Yield | -2.68% |
| Normalized Earnings Yield | -1.564 |